Investor insights
Sectors invested in
Biotechnology2
Biopharma2
Therapeutics1
Pharmaceutical1
Medical1
antigen discovery1
biotechnology1
immunotherapy1
Funding rounds participated in
$125M sweet spot round size
Most of their 3 investments are in rounds between $100M and $125M
Investor type
Venture Capital
Basic info
Industry
hospitals and health care
Sectors
Health Care
Medical
Therapuetics
Life Science
Pharamcueticals
Date founded
2022
Investments made
I
Immunome, Inc. raised $125M on June 29, 2023
Investors: Woodline Partners LP, Avidity Partners, Redmile Group and Enavate Sciences
U
Undisclosed raised $200M on June 8, 2023
Investors: TCG X, Omega Funds, Samsara BioCapital, OrbiMed Advisors, Decheng Capital, Wellington Management and Enavate Sciences
C
CAMP4 Therapeutics raised $100M on July 20, 2022
Investors: 5AM Ventures, Northpond Ventures, Andreessen Horowitz, Polaris Partners and Enavate Sciences